San Francisco Drug Treatment

Published January 10, 2013

San Francisco Drug Treatment – www.altamirarecovery.com

Alnylam Provides Key 2013 – 2014 Goals for RNAi Therapeutics Pipeline

Filed under: drug treatment programs in san francisco

Finally, we are excited today to introduce a new 'Alnylam 5×15' program – ALN-AS1 for the treatment of acute intermittent porphyria, an ultra-rare genetic disease caused by loss of function mutations in an enzyme in the heme biosynthesis pathway that …
Read more on FierceDrugDelivery

Aethlon Medical to Present Today At Biotech Showcase 2013

Filed under: drug treatment programs in san francisco

In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy.
Read more on PR Newswire (press release)

Vertex Outlines Corporate Strategy and Defines Key 2013 Business Priorities

Filed under: drug treatment programs in san francisco

Vertex's Chairman, President and Chief Executive Officer, Jeffrey Leiden, M.D., Ph.D., will discuss the company's strategy and 2013 priorities as part of a live presentation at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on …
Read more on DailyFinance